|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,240 KRW | +0.77% |
|
+2.34% | -15.48% |
| 2023 | PharmGen Science, Inc.(KOSE:A004720) dropped from S&P Global BMI Index | CI |
| 2023 | PharmGen Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
PharmGen Science, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 87.83 million compared to KRW 21.8 million a year ago. Net income was KRW 1,465.69 million compared to KRW 57,942.84 million a year ago.
Basic earnings per share from continuing operations was KRW 93 compared to KRW 3,767 a year ago. Basic earnings per share was KRW 93 compared to KRW 3,767 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.48% | 69.05M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
PHARMGEN SCIENCE, INC. 
